sex

Gonorrhea Might Soon Be Untreatable →

outforhealth:

outforhealth:

OK people, we have a really important thing to say about this. OK. Ready?

If you get antibiotics to treat an STD YOU REALLY GOTTA TAKE ALL OF THEM AS DIRECTED. Even if you feel a bit better, or a sore heals up, or whatever. Seriously. When you do not take all of your meds you may not actually clear up your infection. And what happens then? THIS:

Health officials have been warning us about the threat of “super gonorrhea“—a strain of the sexually transmitted disease that is resistant to all known antibiotics—for over a year. But the superbug is here, much faster than previously anticipated. On Wednesday the Centers for Disease Control and Prevention announced a cluster of gonorrhea infections that shows both decreased susceptibility to ceftriaxone and very high-level resistance to azithromycin. It’s the first time this superbug has been found in the U.S.

Reblogging this because ~this is important~

#health #wellness #sex

Gilead Begins Major Clinical Trial of Descovy vs. Truvada as PrEP - POZ →

Gilead Sciences has begun a major trial to compare the efficacy of Descovy (emtricitabine/tenofovir alafenamide, or TAF) versus Truvada (tenofovir disoproxil fumarate, or TDF/emtricitabine) as pre-exposure prophylaxis (PrEP) against HIV.

In addition to determining how well Descovy protects against HIV compared with Truvada, the trial will compare the drugs’ effects on bone mineral density and kidney function, as well as other safety data.

The U.S. Food and Drug Administration (FDA) approved Descovy in April 2016 to be used in combination with other antiretrovirals (ARVs) to treat HIV. Researchamong HIV-positive people has shown that the drug is less toxic to the bones and kidneys than Truvada. The reason is that Descovy contains an updated version of the drug tenofovir, called TAF, while Truvada contains the older take on that drug, TDF. Both tablets also contain the drug emtricitabine.